NPPA Directs Drugmakers to Revise MRPs After 2026 Duty Exemptions
The National Pharmaceutical Pricing Authority (NPPA) has directed drug manufacturers to revise the maximum retail prices (MRP) of medicines that received customs duty exemptions under the Union Budget 2026.
The National Pharmaceutical Pricing Authority | 12/02/2026 | By Darshana
Government's Price Control Measures on Pharma Products Deliver Annual Savings of INR 25,000 Crore
The National Pharmaceutical Pricing Authority (NPPA) has fixed ceiling prices for 935 scheduled formulations as of early December, resulting in estimated annual savings of around INR 3,802 crore for the public.
The National Pharmaceutical Pricing Authority | 11/12/2025 | By Darshana | 128
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy